Flatiron Health vs Tempus

Side-by-side comparison of Flatiron Health and Tempus: pricing, features, API access, and community ratings.

AI comparison summary

TL;DR

Both platforms offer enterprise-grade oncology AI with large real-world datasets, but Flatiron emphasizes curated, human-validated data quality and has powered significantly more peer-reviewed publications (2,000+), making it stronger for research credibility. Tempus differentiates through its integrated multimodal approach combining genomics, imaging, and EHR data in real-time, plus companion diagnostics capabilities that extend beyond pure data analytics. Choose Flatiron for research-grade evidence generation and Tempus for broader precision medicine workflows that span molecular testing to treatment decisions.

Flatiron Health
Flatiron Health

Real answers to guide oncology's highest-stakes decisions with AI-powered real-world evidence

Visit
Tempus
Tempus

AI-powered precision medicine platform for oncology and clinical insights

Visit
Category
Healthcare & biotech
Healthcare & biotech
Pricing
Enterprise
Enterprise
Starting price
Free tier
Audience
All audiences
All audiences
API available
Open source
Self-hostable
Model provider
Proprietary (LLM + ML)
Proprietary
Founded
2012
2015
Headquarters
New York, USA
Chicago, USA
Key strengths
  • ·High-fidelity oncology real-world data from millions of cancer patients
  • ·AI combined with human expertise for clinical and research insights
  • ·Supports 2,000+ peer-reviewed publications
  • ·Serves both life sciences and point-of-care clinical settings
  • ·One of the world's largest clinico-genomic databases
  • ·AI-driven oncology insights and companion diagnostics
  • ·Real-time data integration across genomics, imaging, and EHR
  • ·Supports physicians with treatment decision support